These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38652080)

  • 1. Cannabidiol potentiates hyperpolarization-activated cyclic nucleotide-gated (HCN4) channels.
    Page DA; Ruben PC
    J Gen Physiol; 2024 Jun; 156(6):. PubMed ID: 38652080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-QT syndrome-associated caveolin-3 mutations differentially regulate the hyperpolarization-activated cyclic nucleotide gated channel 4.
    Motloch LJ; Larbig R; Darabi T; Reda S; Motloch KA; Wernly B; Lichtenauer M; Gebing T; Schwaiger A; Zagidullin N; Wolny M; Hoppe UC
    Physiol Int; 2017 Jun; 104(2):130-138. PubMed ID: 28648120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation and modulation of hyperpolarization-activated HCN4 channels by protein kinase A in the mouse sinoatrial node.
    Liao Z; Lockhead D; Larson ED; Proenza C
    J Gen Physiol; 2010 Sep; 136(3):247-58. PubMed ID: 20713547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanism for the auto-inhibition of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel opening and its relief by cAMP.
    Akimoto M; Zhang Z; Boulton S; Selvaratnam R; VanSchouwen B; Gloyd M; Accili EA; Lange OF; Melacini G
    J Biol Chem; 2014 Aug; 289(32):22205-20. PubMed ID: 24878962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic dinucleotides bind the C-linker of HCN4 to control channel cAMP responsiveness.
    Lolicato M; Bucchi A; Arrigoni C; Zucca S; Nardini M; Schroeder I; Simmons K; Aquila M; DiFrancesco D; Bolognesi M; Schwede F; Kashin D; Fishwick CW; Johnson AP; Thiel G; Moroni A
    Nat Chem Biol; 2014 Jun; 10(6):457-62. PubMed ID: 24776929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular context and multiple channel domains determine cAMP sensitivity of HCN4 channels: ligand-independent relief of autoinhibition in HCN4.
    Liao Z; Lockhead D; St Clair JR; Larson ED; Wilson CE; Proenza C
    J Gen Physiol; 2012 Nov; 140(5):557-66. PubMed ID: 23109717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src tyrosine kinase alters gating of hyperpolarization-activated HCN4 pacemaker channel through Tyr531.
    Li CH; Zhang Q; Teng B; Mustafa SJ; Huang JY; Yu HG
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C355-62. PubMed ID: 17977941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of cannabidiol on voltage-dependent sodium currents.
    Ghovanloo MR; Shuart NG; Mezeyova J; Dean RA; Ruben PC; Goodchild SJ
    J Biol Chem; 2018 Oct; 293(43):16546-16558. PubMed ID: 30219789
    [No Abstract]   [Full Text] [Related]  

  • 9. Pacemaker activity of the human sinoatrial node: effects of HCN4 mutations on the hyperpolarization-activated current.
    Verkerk AO; Wilders R
    Europace; 2014 Mar; 16(3):384-95. PubMed ID: 24569893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRMP inhibits cAMP potentiation of HCN4 channels by disrupting intramolecular signal transduction.
    Peters CH; Singh RK; Langley AA; Nichols WG; Ferris HR; Jeffrey DA; Proenza C; Bankston JR
    Elife; 2024 Apr; 12():. PubMed ID: 38652113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart.
    Stieber J; Herrmann S; Feil S; Löster J; Feil R; Biel M; Hofmann F; Ludwig A
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15235-40. PubMed ID: 14657344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Analyses of Novel HCN4 Gene Mutations.
    Möller M; Silbernagel N; Wrobel E; Stallmayer B; Amedonu E; Rinné S; Peischard S; Meuth SG; Wünsch B; Strutz-Seebohm N; Decher N; Schulze-Bahr E; Seebohm G
    Cell Physiol Biochem; 2018; 49(3):1197-1207. PubMed ID: 30196304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Novel HCN4 Blockers with Unique Blocking Kinetics and Binding Properties.
    Nakashima K; Nakao K; Matsui H
    SLAS Discov; 2021 Aug; 26(7):896-908. PubMed ID: 34041946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-channel properties support a potential contribution of hyperpolarization-activated cyclic nucleotide-gated channels and If to cardiac arrhythmias.
    Michels G; Er F; Khan I; Südkamp M; Herzig S; Hoppe UC
    Circulation; 2005 Feb; 111(4):399-404. PubMed ID: 15687126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heteromeric HCN1-HCN4 channels: a comparison with native pacemaker channels from the rabbit sinoatrial node.
    Altomare C; Terragni B; Brioschi C; Milanesi R; Pagliuca C; Viscomi C; Moroni A; Baruscotti M; DiFrancesco D
    J Physiol; 2003 Jun; 549(Pt 2):347-59. PubMed ID: 12702747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-3 associates with and affects the function of hyperpolarization-activated cyclic nucleotide-gated channel 4.
    Ye B; Balijepalli RC; Foell JD; Kroboth S; Ye Q; Luo YH; Shi NQ
    Biochemistry; 2008 Nov; 47(47):12312-8. PubMed ID: 19238754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutant HCN4 channel in a family with bradycardia, left bundle branch block, and left ventricular noncompaction.
    Yokoyama R; Kinoshita K; Hata Y; Abe M; Matsuoka K; Hirono K; Kano M; Nakazawa M; Ichida F; Nishida N; Tabata T
    Heart Vessels; 2018 Jul; 33(7):802-819. PubMed ID: 29349559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-terminal HCN4 variant P883R alters channel properties and acts as genetic modifier of atrial fibrillation and structural heart disease.
    Weigl I; Geschwill P; Reiss M; Bruehl C; Draguhn A; Koenen M; Sedaghat-Hamedani F; Meder B; Thomas D; Katus HA; Schweizer PA
    Biochem Biophys Res Commun; 2019 Oct; 519(1):141-147. PubMed ID: 31481236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation in S6 domain of HCN4 channel in patient with suspected Brugada syndrome modifies channel function.
    Biel S; Aquila M; Hertel B; Berthold A; Neumann T; DiFrancesco D; Moroni A; Thiel G; Kauferstein S
    Pflugers Arch; 2016 Oct; 468(10):1663-71. PubMed ID: 27553229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-associated HCN4 V759I variant is not sufficient to impair cardiac pacemaking.
    Erlenhardt N; Kletke O; Wohlfarth F; Komadowski MA; Clasen L; Makimoto H; Rinné S; Kelm M; Jungen C; Decher N; Meyer C; Klöcker N
    Pflugers Arch; 2020 Dec; 472(12):1733-1742. PubMed ID: 33095298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.